cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inotiv Inc
2 own
4 watching
Current Price
$6.55
$0.29
(4.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
167.72M
52-Week High
52-Week High
27.22
52-Week Low
52-Week Low
3.645
Average Volume
Average Volume
0.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization167.72M
icon52-Week High27.22
icon52-Week Low3.645
iconAverage Volume0.28M
iconDividend Yield--
iconP/E Ratio--
What does the Inotiv Inc do?
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Read More
How much money does Inotiv Inc make?
News & Events about Inotiv Inc.
CNW Group - News Releases
1month ago
Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market Canada NewsWire SAN ANTONIO, April 11, 2023 Inotiv offersfit-for-purpose drug...
PR Newswire
1month ago
Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market PR Newswire SAN ANTONIO, April 11, 2023 Inotiv offersfit-for-purpose drug testing...
Globe Newswire
3 months ago
WEST LAFAYETTE, Ind., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the Company, We, Our or Inotiv), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, ...
Business Wire
3 months ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Inotiv, Inc. (NasdaqCM: NOTV). On November 5, 2021, the Company completed its purchase of Envigo RMS, LLC...
Globe Newswire
3 months ago
WEST LAFAYETTE, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the Company, We, Our or Inotiv), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, ...
Frequently Asked Questions
Frequently Asked Questions
What is Inotiv Inc share price today?
plus_minus_icon
Can Indians buy Inotiv Inc shares?
plus_minus_icon
How can I buy Inotiv Inc shares from India?
plus_minus_icon
Can Fractional shares of Inotiv Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inotiv Inc stocks?
plus_minus_icon
What is today’s traded volume of Inotiv Inc?
plus_minus_icon
What is today’s market capitalisation of Inotiv Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inotiv Inc?
plus_minus_icon
What percentage is Inotiv Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inotiv Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.55
$0.29
(4.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00